Ask
The Doctor
Dear Doctor is a regular feature of The
Journal, our member publication. Questions are answered by Dr. Remo Panaccione. The following questions are
excerpts from The Journal.

Could canker sores
be related to colitis?
DEAR DOCTOR: I was diagnosed with colitis about a year and a half ago. In the last three months I have not been able
to rid myself of canker sores in my mouth – could they be related to the colitis? I have read that people with my condition can be deficient in iron and the B vitamins, and this could cause cankers. I take a multi-vitamin everyday to try and avoid these deficiencies. I also have a job that is intermittently very stressful, but even when my stress levels subside, I have the cankers. Do you have any suggestions?
DEAR CCFC MEMBER: Canker sores or apthous ulcers are common in people who suffer from inflammatory bowel disease and may occur in approximately 20% of patients with a known diagnosis of Crohn’s or ulcerative colitis. In the absence of other causes (see below) recurrent apthous ulcers may be a sign that the inflammatory bowel disease is not under optimal control. Other causes of recurrent apthous stomatitis include stress, foods (citrus fruits,acidic foods, chocolate), oral trauma and the vitamin deficiencies (Vit. B complex and iron) that you have described.The vitamin deficiencies necessary to cause these problems are rare but can occur in patients with inflammatory bowel disease and should be ruled out. In general, apthous ulcers which occur as part of the spectrum of inflammatory bowel disease come up in crops as opposed to those due to other causes which occur only a few at a time. If you suffer from IBD, the other causes of cankers have been ruled out and vitamin deficiencies have been treated, the next step should be the use of local therapy to the lesions themselves.Topical steroids applied directly to the lesions are very effective and have minimal side effects. Proper oral hygiene with routine dental care, which includes an anti-septic mouthwash, can also help. If this does not help, then I usually recommend re-evaluation and more aggressive treatment of the
underlying inflammatory bowel disease.
Stem Cell Research
DEAR DOCTOR: We hear so much about stem cell
research in the media; can you tell
me what it is and whether it has any
application or benefit for people with
IBD? Are there any investigations
using this approach?
DEAR CCFC MEMBER: In order to answer this question one
needs to understand the technology
and
the debate over this technology. Stem cells
are cells that are able to differentiate into
specialized cell types but also retain the
ability to renew themselves through cell
division. Stem cells were first dentified in
embryos. In an embryonic blastocyst, stem
cells of the inner cell mass proceed to
develop into all of the tissues and organs
of the body. In adults, progenitor cells and
possibly multipotent adult stem cells act as
a repair system for the body, replenishing
more specialized cells.The existence of
truly luripotent stem cells in adult humans
beings is still scientifically controversial.
The use of stem cell transplantation using
an autologous transplantation (deriving
stem cells from one’s own bone marrow
and then re-transplanting as they do in
leukemia and lymphoma) has been
attempted in many autoimmune diseases
including Crohn’s disease.The largest
series has been done by Northwestern
University in Chicago with some
promising results in a small, limited, and
highly select group of patients. However,
the results have sparked enough interest
that several large IBD centers across the
world including the University of Calgary
and the University of Alberta are looking
into studying this further.
An alternative strategy to an autologous
translpant is using adult mesenchymal donor
cells.This is being investigated by a pharma
company in which patients will receive two
treatments of adult mesenchymal stem cells
for the the treatment of Crohn’s disease.
These cells are like receiving Type O blood
(they are universally accepted) into the host.
The hope is that this therapy will help heal
damaged intestine.
Do acne medicines
increase IBD risk?
DEAR DOCTOR: Someone told me recently that
she saw an article, which stated
people taking Accutane for the
treatment of acne had an increased
risk of developing inflammatory bowel
disease. Can you tell us what you
know about this? And are there
concerns about other acne medicines?
DEAR CCFC MEMBER: The question is very interesting and
very topical. Isotretinoin (Accutane) is
a
very common treatment for patients with
moderate to severe acne.There have been
several reports over the years that the
therapy can cause a flare of inflammatory
bowel disease in patients with established
disease. Most of this opinion comes from
observation and temporal relationship to
the initiation of the drug and the flare
of IBD. Regardless, I usually counsel my
patients and local dermatologists to proceed
with caution when considering this
therapy. Alternatives should be explored.
More recently, a study (published by Reddy
and colleagues in the July 2006 issue of the
American Journal of Gastroenterology) looked
at all cases of IBD reported to the Food
and Drug Administration (FDA) in the
United States in conjunction with the use
of Isotretinoin between 1997 and 2002.
They found 85 cases and concluded that
there was a possible link between the two.
A good rule of thumb if you
are a patient with IBD is to
discuss any new medication
with your physician to ensure it
has not been associated with
causing a flare of the disease.
The only other acne medication that
may trigger flares of IBD is Minocycline
(Minocin) which is a powerful antibiotic.
A good rule of thumb if you are a
patient with IBD is to discuss any new
medication with your physician to ensure
it has not been associated with causing a
flare of the disease.
What are biological
therapies?
DEAR DOCTOR: What are biological therapies?
What do they do for people with
Crohn’s Disease?
DEAR CCFC MEMBER: Biological therapy refers to the use of medication that is tailored to specifically target an immune or genetic mediator of disease. Even for diseases of unknown cause, such as Crohn’s disease and ulcerative colitis, molecules that are involved in the disease process have been identified, and can be targeted for biological therapy. Biological therapy refers to therapy that is produced using techniques of bioengineering.These drugs are usually directed against known targets or pathways
which are believed to be important in either causing inflammation or enhancing the ability of the body to dampen the inflammatory response or improve healing. Examples of drugs which are considered biological therapy in Crohn’s
disease include infliximab (Remicade®), adalimumab (Humira®) and certolizumab (Cimzia®) all of which are targeted against tumour necrosis factor alpha (TNF alpha), a molecule in the body which is believed to be important in the development and
propagation of inflammation. These drugs have all been shown to be very important in their ability to inhibit the effects of TNF alpha and therefore reduce the signs and symptoms of Crohn’s disease and ulcerative colitis.They are considered to be the most significant advances in the therapy of inflammatory bowel disease in the last decade.
Colitis or Crohn’s?
DEAR DOCTOR: I was first diagnosed with ulcerative colitis, and four years ago my colon was removed. The diagnosis was changed to Crohn’s disease because surgery revealed that more than one layer of bowel tissue was affected. All my other symptoms were related to colitis, not Crohn’s. Is it possible for colitis to worsen and attack deeper tissue layers? Does that alone change the diagnosis from colitis to Crohn’s? Is this common?
DEAR CCFC MEMBER: I always try to educate patients on the difference between ulcerative colitis and Crohn’s disease. Ulcerative colitis only affects the colon; Crohn’s disease can affect any portion of the gastrointestinal tract including just the colon – which it does in 25 per cent of cases. Therefore “colitis” can be ulcerative colitis or Crohn’s disease (Crohn’s colitis) and the symptoms are
indistinguishable.
An experienced physician can usually tell the difference between the two. But in 5-10% of IBD cases, there is no clear distinction (so called indeterminate colitis). The true nature of the disease is apparent only at surgery, when the larger specimen is available to the pathologist (the doctor who examines the surgical specimen). Once again, an experienced pathologist can tell the difference, especially in surgical specimens. From your description, it sounds like the pathologist is seeing transmural inflammation, raising the question of Crohn’s disease.
About Molo-cure
DEAR DOCTOR: What can you tell me about Molo-cure? A website claims it is a “natural solution” that can cure IBD.
DEAR CCFC MEMBER: It’s always difficult for a physician like myself to answer questions regarding alternative products or methods that claim to control inflammatory bowel disease.
Molo-cure or Aloe mucilaginous polysaccharide (A.M.P) is probably a safe and non-toxic compound which in theory, may aid in the digestive process. But it HAS NEVER BEEN EVALUATED SCIENTIFICALLY in patients with IBD. It may not be harmful, but I would caution patients about believing claims on their website. Just as you would be skeptical about infomercials that claim the 200 pound individual turns into a sculpted god or goddess overnight, you should be equally skeptical when reading the claims of Molo-cure. Again, when counseling patients, I stress that if it was that easy, we’d all be using it! Certainly, as a physician, I would prefer to prescribe an all natural product that is proven instead of a drug that has potential side effects. If the proponents of this and similar products truly had the best interest of patients in mind, it would make sense that they would perform a proper investigation.
Definitions:
Molo-cure: (Aloe Mucilaginous Polysaccharide) natural food substance derived from the aloe vera plant in capsule form. The manufacturer claims that through “specific enhancement of the body’s defense mechanisms” the
product may alleviate symptoms of digestive system disease or disorder. |